Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-08

Clinical Trial Update: Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a dual therapy regimen in HIV patients comparing 4 days per week versus 7 days per week; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV Infections | Phase 3 | Status: UNKNOWN